Bowenoid dysplasia of the vulva

Thomas Ulbright, Frederick Stehman, L. M. Roth, C. E. Ehrlich, R. C. Ransburg

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The histologic findings of 5 patients with clinically typical Bowenoid dysplasia (BD) allowed the authors to classify the vulvar and perineal biopsies of 18 patients under 40 years as BD and the vulvar biopsies of 6 patients under 40 years as squamous cell carcinoma in situ (CIS). The two best criteria for BD are cellular uniformity and absence of pilosebaceous involvement. Vesicular chromatin is a less constant feature of BD. Clinically, patients with BD were younger than those with CIS, more frequently had elevated and multiple lesions and often developed BD with pregnancy. Histologic features therefore discriminate between clinical BD and CIS, but the authors emphasize that both clinical and pathologic features are necessary for proper diagnosis. Follow-up of BD has been benign, with one exception. Spontaneous regression occasionally occurred. One patient with CIS developed microinvasive carcinoma. Patients with BD were regarded at lesser risk for invasive carcinoma than patients with CIS; they are therefore amenable to conservative therapy.

Original languageEnglish
Pages (from-to)2910-2919
Number of pages10
JournalCancer
Volume50
Issue number12
DOIs
StatePublished - 1982

Fingerprint

Vulva
Carcinoma in Situ
Carcinoma
Biopsy
Chromatin
Squamous Cell Carcinoma
Pregnancy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Bowenoid dysplasia of the vulva. / Ulbright, Thomas; Stehman, Frederick; Roth, L. M.; Ehrlich, C. E.; Ransburg, R. C.

In: Cancer, Vol. 50, No. 12, 1982, p. 2910-2919.

Research output: Contribution to journalArticle

Ulbright, Thomas ; Stehman, Frederick ; Roth, L. M. ; Ehrlich, C. E. ; Ransburg, R. C. / Bowenoid dysplasia of the vulva. In: Cancer. 1982 ; Vol. 50, No. 12. pp. 2910-2919.
@article{bd4abdf180294a9f9cb7356d1b1ed5f5,
title = "Bowenoid dysplasia of the vulva",
abstract = "The histologic findings of 5 patients with clinically typical Bowenoid dysplasia (BD) allowed the authors to classify the vulvar and perineal biopsies of 18 patients under 40 years as BD and the vulvar biopsies of 6 patients under 40 years as squamous cell carcinoma in situ (CIS). The two best criteria for BD are cellular uniformity and absence of pilosebaceous involvement. Vesicular chromatin is a less constant feature of BD. Clinically, patients with BD were younger than those with CIS, more frequently had elevated and multiple lesions and often developed BD with pregnancy. Histologic features therefore discriminate between clinical BD and CIS, but the authors emphasize that both clinical and pathologic features are necessary for proper diagnosis. Follow-up of BD has been benign, with one exception. Spontaneous regression occasionally occurred. One patient with CIS developed microinvasive carcinoma. Patients with BD were regarded at lesser risk for invasive carcinoma than patients with CIS; they are therefore amenable to conservative therapy.",
author = "Thomas Ulbright and Frederick Stehman and Roth, {L. M.} and Ehrlich, {C. E.} and Ransburg, {R. C.}",
year = "1982",
doi = "10.1002/1097-0142(19821215)50:12<2910::AID-CNCR2820501234>3.0.CO;2-R",
language = "English",
volume = "50",
pages = "2910--2919",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Bowenoid dysplasia of the vulva

AU - Ulbright, Thomas

AU - Stehman, Frederick

AU - Roth, L. M.

AU - Ehrlich, C. E.

AU - Ransburg, R. C.

PY - 1982

Y1 - 1982

N2 - The histologic findings of 5 patients with clinically typical Bowenoid dysplasia (BD) allowed the authors to classify the vulvar and perineal biopsies of 18 patients under 40 years as BD and the vulvar biopsies of 6 patients under 40 years as squamous cell carcinoma in situ (CIS). The two best criteria for BD are cellular uniformity and absence of pilosebaceous involvement. Vesicular chromatin is a less constant feature of BD. Clinically, patients with BD were younger than those with CIS, more frequently had elevated and multiple lesions and often developed BD with pregnancy. Histologic features therefore discriminate between clinical BD and CIS, but the authors emphasize that both clinical and pathologic features are necessary for proper diagnosis. Follow-up of BD has been benign, with one exception. Spontaneous regression occasionally occurred. One patient with CIS developed microinvasive carcinoma. Patients with BD were regarded at lesser risk for invasive carcinoma than patients with CIS; they are therefore amenable to conservative therapy.

AB - The histologic findings of 5 patients with clinically typical Bowenoid dysplasia (BD) allowed the authors to classify the vulvar and perineal biopsies of 18 patients under 40 years as BD and the vulvar biopsies of 6 patients under 40 years as squamous cell carcinoma in situ (CIS). The two best criteria for BD are cellular uniformity and absence of pilosebaceous involvement. Vesicular chromatin is a less constant feature of BD. Clinically, patients with BD were younger than those with CIS, more frequently had elevated and multiple lesions and often developed BD with pregnancy. Histologic features therefore discriminate between clinical BD and CIS, but the authors emphasize that both clinical and pathologic features are necessary for proper diagnosis. Follow-up of BD has been benign, with one exception. Spontaneous regression occasionally occurred. One patient with CIS developed microinvasive carcinoma. Patients with BD were regarded at lesser risk for invasive carcinoma than patients with CIS; they are therefore amenable to conservative therapy.

UR - http://www.scopus.com/inward/record.url?scp=0020462024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020462024&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19821215)50:12<2910::AID-CNCR2820501234>3.0.CO;2-R

DO - 10.1002/1097-0142(19821215)50:12<2910::AID-CNCR2820501234>3.0.CO;2-R

M3 - Article

C2 - 7139580

AN - SCOPUS:0020462024

VL - 50

SP - 2910

EP - 2919

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 12

ER -